6-31687890-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021160.3(ABHD16A):āc.1381G>Cā(p.Val461Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000243 in 1,612,786 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021160.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD16A | NM_021160.3 | c.1381G>C | p.Val461Leu | missense_variant | 17/20 | ENST00000395952.8 | NP_066983.1 | |
ABHD16A | NM_001177515.2 | c.1282G>C | p.Val428Leu | missense_variant | 15/18 | NP_001170986.1 | ||
ABHD16A | NR_033488.2 | n.1596G>C | non_coding_transcript_exon_variant | 17/20 | ||||
ABHD16A | NR_033489.2 | n.1300G>C | non_coding_transcript_exon_variant | 15/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD16A | ENST00000395952.8 | c.1381G>C | p.Val461Leu | missense_variant | 17/20 | 1 | NM_021160.3 | ENSP00000379282.3 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000463 AC: 114AN: 246418Hom.: 3 AF XY: 0.000402 AC XY: 54AN XY: 134306
GnomAD4 exome AF: 0.000246 AC: 359AN: 1460654Hom.: 4 Cov.: 33 AF XY: 0.000256 AC XY: 186AN XY: 726624
GnomAD4 genome AF: 0.000217 AC: 33AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74322
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.1381G>C (p.V461L) alteration is located in exon 17 (coding exon 17) of the ABHD16A gene. This alteration results from a G to C substitution at nucleotide position 1381, causing the valine (V) at amino acid position 461 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at